INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
98.38 USD
+3.38 (+3.56%)
98.38 USD
0 (0%)
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
INSP had positive earnings in the past year.
INSP had a positive operating cash flow in the past year.
In the past 5 years INSP reported 4 times negative net income.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.52%, INSP belongs to the best of the industry, outperforming 82.16% of the companies in the same industry.
INSP's Return On Equity of 6.69% is amongst the best of the industry. INSP outperforms 81.08% of its industry peers.
INSP has a Return On Invested Capital of 4.82%. This is in the better half of the industry: INSP outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a better Profit Margin (5.05%) than 77.30% of its industry peers.
INSP has a better Operating Margin (4.16%) than 68.65% of its industry peers.
The Gross Margin of INSP (84.92%) is better than 94.05% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
INSP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for INSP has been increased compared to 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INSP has an Altman-Z score of 13.60. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 13.60, INSP belongs to the best of the industry, outperforming 91.35% of the companies in the same industry.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.6 |
ROIC/WACC0.49
WACC9.81%
2.3 Liquidity
INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INSP (5.29) is better than 81.08% of its industry peers.
INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INSP (4.01) is better than 76.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.65% over the past year.
INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 57.78% on average per year.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.80% on average per year.
Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 11.14% on average per year.
EPS Next Y-38.85%
EPS Next 2Y1.25%
EPS Next 3Y15.12%
EPS Next 5Y18.8%
Revenue Next Year13.2%
Revenue Next 2Y12.21%
Revenue Next 3Y12.2%
Revenue Next 5Y11.14%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
INSP is valuated quite expensively with a Price/Earnings ratio of 48.23.
69.73% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.19. INSP is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 55.47, INSP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 68.65% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (23.92), we can say INSP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.23 | ||
| Fwd PE | 55.47 |
4.2 Price Multiples
66.49% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, INSP is valued cheaper than 81.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.93 | ||
| EV/EBITDA | 47.15 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 15.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.25%
EPS Next 3Y15.12%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
98.38
+3.38 (+3.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners111.59%
Inst Owner Change0.99%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap2.86B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target144.32 (46.7%)
Short Float %12.07%
Short Ratio2.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)12.65%
PT rev (3m)3.29%
EPS NQ rev (1m)-1.63%
EPS NQ rev (3m)-0.13%
EPS NY rev (1m)13.12%
EPS NY rev (3m)110.93%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.91%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.23 | ||
| Fwd PE | 55.47 | ||
| P/S | 3.24 | ||
| P/FCF | 28.93 | ||
| P/OCF | 21.39 | ||
| P/B | 4.29 | ||
| P/tB | 4.29 | ||
| EV/EBITDA | 47.15 |
EPS(TTM)2.04
EY2.07%
EPS(NY)1.77
Fwd EY1.8%
FCF(TTM)3.4
FCFY3.46%
OCF(TTM)4.6
OCFY4.68%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 13.6 |
F-Score8
WACC9.81%
ROIC/WACC0.49
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-38.85%
EPS Next 2Y1.25%
EPS Next 3Y15.12%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.2%
Revenue Next 2Y12.21%
Revenue Next 3Y12.2%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.93%
EBIT Next 3Y123.99%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 48.23 and the Price/Book (PB) ratio is 4.29.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.